基于国产高端腔镜和新辅助治疗降期的支气管肺段袖式切除术临床效果评价

Evaluation on the clinical effect of the resection of innovative sleeve type on bronchopulmonary segment based on domestically high-end endoscope and new adjuvant therapy at downstage

目的:探究基于国产高端腔镜和新辅助治疗降期的支气管肺段袖式切除术临床应用效果。方法:选取医院收治的20例新辅助治疗后行肺切除术的患者,按随机数表法将其分为观察组和对照组,每组10例。对照组予以传统肺叶切除术,观察组予以联合国产高端腔镜的支气管肺段袖式切除术,收集两组患者术中术后临床资料,并对两组患者围手术期指标和短期预后结果等进行统计分析。结果:观察组患者术后住院天数少于对照组,差异有统计学意义(Z=-1.991,P<0.05),术后并发症发生率均少于对照组,差异有统计学意义(x^(2)=7.200,P<0.05);观察组和对照组平均手术时间分别为(3.38±0.42)h和(2.61±0.33)h,其差异无统计学意义(t=1.445,P>0.05)。两组出血量和淋巴结清扫数比较,差异均无统计学意义(Z=-0.173,Z=-1.432;P>0.05)。结论:基于国产高端腔镜系统和新辅助治疗降期可以安全、有效地实行支气管肺段袖式切除等创新术式,发展、支持、应用国产高端腔镜系统有助于进一步实现肺部肿瘤微创术式创新。

Objective:To explore the clinical application effect of resection of sleeve type on bronchopulmonary segment based on domestically high-end endoscope and new adjuvant therapy at downstage.Methods:A total of 20 patients who underwent pneumonectomy after new adjuvant therapy were selected and they were divided into observation group and control group according to random number table method,with 10 patients in each group.The control group received conventional lobectomy,while the observation group received the resection of sleeve type on bronchopulmonary segment that combined with domestic high-end endoscope.The clinical data of two groups were collected,and the perioperative indicators and short-term prognosis results were analyzed as statistical methods.Results:The hospitalization days after surgery in observation group was significantly less than that in control group,and the complications after surgery in observation group also was less than that in control group,with statistically significant differences(Z=-1.991,x^(2)=7.200,P<0.05),respectively.The operation times of observation group and control group were respectively(3.38±0.42)h and(2.61±0.33)h,without statistically significant difference between two groups(t=1.445,P>0.05).There were no statistically significant differences in the bleeding volume and the number of lymph node clearance(Z=-0.173,Z=-1.432,P>0.05).Conclusion:Based on the domestic high-end endoscopic system and the new adjuvant therapy at downstage,the innovatively surgical modes such as the resection of sleeve type on bronchopulmonary segment can be safely and effectively implemented.The development,support and application of domestic high-end endoscopic system will help to further realize the innovation of minimally invasive surgery for lung tumor.